Monday, October 17, 2011
New Stent Provides Relief to Patients with Advanced Small Intestine Cancer
Cook Medical announced today that its Evolution® Duodenal Controlled-Release Stent was recently granted 510(k) clearance by the FDA. The new stent expands palliative care options for patients experiencing malignant gastric outlet obstruction, a late stage complication of a variety of GI related cancers with pancreatic cancer being the most common cause. The stent offers these patients a minimally invasive alternative to relieve the symptoms and potentially life-threatening complications resulting from duodenal obstruction, such as abdominal pain, vomiting, malnutrition and aspiration.